Clinical Drug Experience Knowledgebase

bevacizumab (avastin) (2 trials)

capecitabine (xeloda) (3 trials)

everolimus (zortress) (1 trial)

exemestane (aromasin) (1 trial)

celecoxib (celebrex) (1 trial)

docetaxel (taxotere) (3 trials)

fluorouracil (efudex) (2 trials)

leucovorin (2 trials)

mitoxantrone (novantrone) (1 trial)

oxaliplatin (eloxatin) (1 trial)

pertuzumab (perjeta) (1 trial)

trastuzumab (herceptin) (2 trials)

vinorelbine (navelbine) (3 trials)

bendamustine (treanda) (1 trial)

cyclophosphamide (cytoxan) (1 trial)

doxorubicin (Doxil) (1 trial)

pemetrexed (alimta) (1 trial)

lapatinib (tykerb) (1 trial)